Novavax becomes Australia’s 5th approved COVID-19 vaccine

Novavax becomes Australia’s 5th approved COVID-19 vaccine

The country has ordered 51 million doses of the U.S.-manufactured vaccine, supplied under the brand Nuvaxovid, for its population of 26 million. Novavax’s COVID-19 vaccine on Thursday became the fifth coronavirus vaccine approved for use in Australia.The country has ordered 51 million doses of the U.S.-manufactured vaccine, supplied under the brand Nuvaxovid, for its population … Read more

Drop in COVID Vaccine Effectiveness Suggests Need for Boosters

Drop in COVID Vaccine Effectiveness Suggests Need for Boosters

Dec. 10, 2021 — The effectiveness of the two most common COVID-19 vaccines declined over time in an older group of patients, suggesting that booster doses may be needed to protect recipients over the long term, according to a new study. Also seen in that group of U.S. veterans, who had a median age of … Read more

Moderna Warns of ‘Material Drop’ in Vaccine Efficacy Against Omicron

Moderna Warns of ‘Material Drop’ in Vaccine Efficacy Against Omicron

Nov. 30, 2021 — The Moderna CEO says existing COVID-19 vaccines will likely be less effective against the new Omicron variant. “There is no world, I think, where [the effectiveness] is the same level … we had with Delta,” Stephane Bancel told the Financial Times. “I think it’s going to be a material drop,” he … Read more

COVID-19 booster shots to be availed for more people in the US; check who can get the vaccine booster shots

COVID-19 booster shots to be availed for more people in the US; check who can get the vaccine booster shots

Those under the age-bracket of 18–49 years with underlying medical conditions may receive a booster shot at least 6 months after receiving both the doses for their Pfizer-BioNTech vaccine (Photo: Reuters) The US Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunisation Practices (ACIP) recommended Pfizer-BioNTech vaccine as a booster shot for certain … Read more

Moderna produces more antibodies in the blood after getting the second dose than Pfizer: Study

Moderna produces more antibodies in the blood after getting the second dose than Pfizer: Study

Moderna vaccine produces more antibodies in the blood after getting the second dose than Pfizer, reveals study (Reuters Photo) Covid-19 vaccination: The recent study shows that antibody levels in recipients of the Moderna vaccine were comparatively higher than in those recipients of the Pfizer vaccine. The findings were published recently in JAMA Network Open and … Read more

Potency of Pfizer, Moderna vaccines falling with passage of time: Study

Potency of Pfizer, Moderna vaccines falling with passage of time: Study

The study has been carried in the Morbidity Mortality Weekly Report from the US Centers for Disease Control and Prevention (CDC). In what appears to be an unfortunate development, scientists have found that the potency or effectiveness of Coronavirus vaccines has diminished in recent months. The findings which have been published by the scientists at … Read more

Covid-19: Waning vaccine efficiency, high pre-symptomatic transmission behind Delta variant’s rapid spread

Covid-19: Waning vaccine efficiency, high pre-symptomatic transmission behind Delta variant’s rapid spread

Recent epidemiological research has found the Delta (B.1.617.2) variant to be 40 per cent more contagious than the Alpha variant Reduced vaccine efficiency and high infectiousness during the pre-symptomatic phase are leading to rapid transmission of the coronavirus’ Delta variant, several studies have found. Recent epidemiological research has found the Delta (B.1.617.2) variant to be … Read more

Covid-19: Vaccine effectiveness against Delta variant wanes over time, new study finds

Covid-19: Vaccine effectiveness against Delta variant wanes over time, new study finds

University of Oxford and Office for National Statistics researchers conducted the study, the results of which were published in a pre-print The effectiveness of Oxford-AstraZeneca and Pfizer-BioNTech vaccines against the Delta variant of the coronavirus wanes over time despite offering considerable protection against the strain, a UK study has found. University of Oxford and Office … Read more

Covid-19: Cipla gets India go-ahead to import Moderna vaccine

Covid-19: Cipla gets India go-ahead to import Moderna vaccine

The indemnity issue was being addressed and under consideration Paul said. Moderna’s Covid vaccine has been granted permission for restricted use in India. The Drugs Controller General of India on Tuesday approved application from Cipla, which is partnering with Moderna, to import the vaccines for restricted use in the country. The mRNA vaccine was cleared … Read more

CDC looking into reports of heart inflammation after Pfizer, Moderna vaccine 2nd jab

CDC looking into reports of heart inflammation after Pfizer, Moderna vaccine 2nd jab

US health officials are investigating what appear to be higher than expected reports of heart inflammation in male teens and young adults after they get a second dose of the and Moderna vaccines. It’s not clear if the heart inflammation is caused by the shots and the reports still are rare, according to the Centers … Read more